טוען...

Difluprednate ophthalmic emulsion 0.05% (Durezol(®)) administered two times daily for managing ocular inflammation and pain following cataract surgery

OBJECTIVE: To evaluate the efficacy and safety of twice-daily difluprednate ophthalmic emulsion 0.05% (Durezol(®)) versus placebo administered before surgery for managing inflammation and pain following cataract extraction. METHODS: Eligible subjects (N = 121) were randomized 2:1 to topical treatmen...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Smith, Stephen, Lorenz, Douglas, Peace, James, McLeod, Kimberly, Crockett, RS, Vogel, Roger
פורמט: Artigo
שפה:Inglês
יצא לאור: Dove Medical Press 2010
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2938279/
https://ncbi.nlm.nih.gov/pubmed/20856594
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!